SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 13 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $7,000 | -84.8% | 60,995 | +126.7% | 0.00% | – |
| Q3 2018 | $46,000 | -47.7% | 26,904 | -47.1% | 0.00% | -100.0% |
| Q2 2018 | $88,000 | +183.9% | 50,846 | +203.6% | 0.00% | – |
| Q1 2018 | $31,000 | -24.4% | 16,748 | -10.0% | 0.00% | – |
| Q4 2017 | $41,000 | -63.1% | 18,600 | -51.3% | 0.00% | -100.0% |
| Q3 2017 | $111,000 | +13.3% | 38,232 | +73.8% | 0.00% | 0.0% |
| Q2 2017 | $98,000 | +6.5% | 22,002 | +11.8% | 0.00% | 0.0% |
| Q1 2017 | $92,000 | -81.5% | 19,673 | -75.9% | 0.00% | -75.0% |
| Q4 2016 | $497,000 | +137.8% | 81,652 | +115.7% | 0.00% | +100.0% |
| Q3 2016 | $209,000 | -95.6% | 37,859 | -97.0% | 0.00% | -94.1% |
| Q2 2016 | $4,729,000 | +35.2% | 1,244,557 | -1.8% | 0.03% | +36.0% |
| Q1 2016 | $3,498,000 | +2216.6% | 1,267,412 | +4358.3% | 0.02% | +2400.0% |
| Q3 2015 | $151,000 | +277.5% | 28,428 | +117.9% | 0.00% | – |
| Q4 2014 | $40,000 | -42.9% | 13,048 | -23.6% | 0.00% | – |
| Q2 2014 | $70,000 | +6.1% | 17,079 | +18.9% | 0.00% | – |
| Q3 2013 | $66,000 | – | 14,365 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 477,621 | $1,065,000 | 1.44% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,505,804 | $3,358,000 | 1.18% |
| Nantahala Capital Management | 7,000,000 | $15,610,000 | 0.69% |
| Hikari Power Ltd | 1,900,000 | $4,237,000 | 0.50% |
| Trellus Management Company, LLC | 112,500 | $251,000 | 0.34% |
| Cheyne Capital Management (UK) LLP | 206,500 | $462,000 | 0.20% |
| KNOTT DAVID M | 201,400 | $449,000 | 0.18% |
| Paulson & Co. | 4,000,000 | $8,920,000 | 0.17% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,041,695 | $2,323,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 318,460 | $710,000 | 0.13% |